MDM2 and soft tissue sarcoma: Previous studies have shown that MDM2 is involved in cancer cell proliferation by activating platelet-derived growth factor and deubiquitinating, and is overexpressed in many soft-tissue sarcomas, such as osteosarcoma [41], retroperitoneal liposarcoma [42], and liposarcoma [43].